Literature DB >> 28428309

Draft Genome Sequences of Two Highly Erythromycin-Resistant Streptococcus gallolyticus subsp. gallolyticus Isolates Containing a Novel Tn916-Like Element, Tn6331.

Stanimir Kambarev1, Frédéric Pecorari1, Stéphane Corvec2,3.   

Abstract

Recently, we reported the draft genome sequence of Streptococcus gallolyticus NTS31106099. It was found to contain a previously unknown putative Tn916-like conjugative transposon, Tn6263 Here, we report the draft genome sequences of two other clinical isolates, NTS31301958 and NTS31307655. Both of them contain another novel element, Tn6331, which is highly similar to Tn6263.
Copyright © 2017 Kambarev et al.

Entities:  

Year:  2017        PMID: 28428309      PMCID: PMC5399268          DOI: 10.1128/genomeA.00226-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Streptococcus gallolyticus subsp. gallolyticus is a Gram-positive gastrointestinal commensal and opportunistic pathogen often found in animals and humans. The clinical relevance of S. gallolyticus subsp. gallolyticus (previously Streptococcus bovis biotype I) to humans is due to its ability to occasionally cause various clinical entities, mainly infective endocarditis and bacteremia (1, 2). Furthermore, the bacterium has been shown to be closely associated with the presence of colorectal malignancy (3). However, the virulence arsenal and pathogenesis of S. gallolyticus subsp. gallolyticus remain poorly understood (2, 4, 5). Its first sequenced genomes were released almost a decade ago, and early comparative analysis has suggested an active involvement of S. gallolyticus subsp. gallolyticus in horizontal gene transfer with other rumen or gut Firmicutes, such as enterococci, lactobacilli, bacilli, and clostridia (6–9). Surprisingly, even tough epidemiological studies have shown a high prevalence of erythromycin-resistant isolates (10, 11) and the number of sequenced S. gallolyticus subsp. gallolyticus genomes continues to grow steadily, mobile elements encoding macrolide resistance determinants have not yet been described in this organism. Only a limited number of such elements have been characterized in the other S. gallolyticus subspecies, S. gallolyticus subsp. pasteurianus (12–15). Recently, we reported the draft genome sequence of highly erythromycin-resistant clinical isolate S. gallolyticus subsp. gallolyticus NTS31106099 (16). It was found to contain previously unknown putative Tn916-like conjugative transposon, Tn6263, which harbors an aminoglycoside/macrolide resistance cluster [aph(3′)-III→ant(6)-Ia→ermB]. Here, we present the draft genome sequences of two other highly erythromycin-resistant isolates of S. gallolyticus subsp. gallolyticus, NTS31301958 and NTS31307655. They contain another previously unknown element, Tn6331, which is highly similar to Tn6263 and harbors an identical resistance cluster. Cultures and genomic DNA were prepared as described elsewhere (16). Genome fragmentation was performed with Bioruptor Standard (Diagenode). About 1 µg of fragmented DNA (200 to 300 bp) was used for preparation of sequencing libraries using the NEBNext Ultra DNA library prep kit for Illumina (NEB) and sequenced on a MiSeq sequencer (Illumina). The draft sequences of NTS31301958 and NTS31307655 were assembled de novo from 1,499,382 and 1,710,880 high-quality 150-bp paired-end reads, respectively, using Velvet 1.2.10 (17) and VelvetOptimiser 2.2.5 (18). The resulting sets of contigs were reordered against the complete genome of strain UCN34 (7) using Mauve 1.2.10 (19) and annotated through the NCBI Prokaryotic Genome Automatic Annotation Pipeline (20). De novo assembly of the NTS31301958 genome resulted in a set of 22 contigs, with an average coverage of 96× and an N50 of 1,180 kb. The draft sequence has a total length of 2,330,998 bp and G+C content of 37.5%. About 2,253 coding sequences (CDSs) were automatically annotated, including 42 pseudogenes and 67 RNA genes. The draft genome of isolate NTS31307655 consists of 30 contigs, with an average coverage of 103× and an N50 of 272 kb. The sequence is 2,332,206 bp long and has a G+C content of 37.5%. Annotation revealed 2,254 CDSs, 49 pseudogenes, and 67 RNA genes.

Accession number(s).

The draft genomes of S. gallolyticus subsp. gallolyticus NTS31301958 and NTS31307655 sequenced under this project have been deposited at DDBJ/EMBL/GenBank under the accession numbers MAMV00000000 and LXFC00000000, respectively. The versions described in this paper are MAMV01000000 and LXFC01000000.
  20 in total

1.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

2.  The erm(T) gene is flanked by IS1216V in inducible erythromycin-resistant Streptococcus gallolyticus subsp. pasteurianus.

Authors:  Jui-Chang Tsai; Po-Ren Hsueh; Hsiao-Jan Chen; Sung-Pin Tseng; Pei-Yu Chen; Lee-Jene Teng
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.

Authors:  Viola C Y Chow; Peter M Hawkey; Edward W C Chan; Miu L Chin; T K Au; Danny K C Fung; Raphael C Y Chan
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

4.  The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease.

Authors:  Annemarie Boleij; Harold Tjalsma
Journal:  Lancet Infect Dis       Date:  2013-07-05       Impact factor: 25.071

Review 5.  Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis.

Authors:  Annemarie Boleij; Marleen M H J van Gelder; Dorine W Swinkels; Harold Tjalsma
Journal:  Clin Infect Dis       Date:  2011-09-29       Impact factor: 9.079

6.  Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis.

Authors:  Christophe Rusniok; Elisabeth Couvé; Violette Da Cunha; Rachida El Gana; Nora Zidane; Christiane Bouchier; Claire Poyart; Roland Leclercq; Patrick Trieu-Cuot; Philippe Glaser
Journal:  J Bacteriol       Date:  2010-02-05       Impact factor: 3.490

Review 7.  Microbes, microbiota, and colon cancer.

Authors:  Cynthia L Sears; Wendy S Garrett
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

8.  Sequencing and comparative genome analysis of two pathogenic Streptococcus gallolyticus subspecies: genome plasticity, adaptation and virulence.

Authors:  I-Hsuan Lin; Tze-Tze Liu; Yu-Ting Teng; Hui-Lun Wu; Yen-Ming Liu; Keh-Ming Wu; Chuan-Hsiung Chang; Ming-Ta Hsu
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

9.  The gut as reservoir of antibiotic resistance: microbial diversity of tetracycline resistance in mother and infant.

Authors:  Lisbeth E de Vries; Yvonne Vallès; Yvonne Agersø; Parag A Vaishampayan; Andrea García-Montaner; Jennifer V Kuehl; Henrik Christensen; Miriam Barlow; M Pilar Francino
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

10.  Draft Genome Sequence of Erythromycin-Resistant Streptococcus gallolyticus subsp. gallolyticus NTS 31106099 Isolated from a Patient with Infective Endocarditis and Colorectal Cancer.

Authors:  Stanimir Kambarev; Clément Caté; Stéphane Corvec; Frédéric Pecorari
Journal:  Genome Announc       Date:  2015-04-23
View more
  2 in total

1.  Detection of Streptococcus gallolyticus in colorectal cancer and inflammatory bowel disease patients compared to control group in southwest of Iran.

Authors:  Ahmad Farajzadeh Sheikh; Abdol Rahim Masjedi Zadeh; Morteza Saki; Parisa Khani; Seyed Jalal Hashemi; Sam Shahin Zadeh; Maryam Dastoorpoor
Journal:  Mol Biol Rep       Date:  2020-10-31       Impact factor: 2.316

2.  Suppurative meningoencephalitis and perineuritis caused by Streptococcus gallolyticus in a Japanese Black calf.

Authors:  Mikuya Iwanaga; Naoto Imai; Ayaka Kamikawa; Kaho Shimada; Masatoshi Okura; Daisuke Takamatsu; Daijiro Ueda; Mizuki Nakayama; Tomoyuki Shibahara
Journal:  J Vet Med Sci       Date:  2021-11-23       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.